Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Austin Mark John
VP Finance/Prin Fin&Acct Offic at Perspective Therapeutics. Filing since 21 Nov 2017.
CIK 0001713059
Company
Date
Role
Action
Shares
Amount
Of holding
CATX
Perspective Therapeutics, Inc.
9 Jun 2022
VP Finance/Prin Fin&Acct Offic
Bought
13,800
$3.96K
34.3%
CATX
Perspective Therapeutics, Inc.
8 Jun 2022
VP Finance/Prin Fin&Acct Offic
Bought
5,000
$1.43K
14.2%
CATX
Perspective Therapeutics, Inc.
22 Oct 2020
Controller/Prin Fin&Acct Offic
Bought
19,230
$10.00K
120%
CATX
Perspective Therapeutics, Inc.
16 Nov 2018
Controller/Prin Fin&Acct Offic
Bought
4,283
$1.70K
36.6%
CATX
Perspective Therapeutics, Inc.
13 Nov 2018
Controller/Prin Fin&Acct Offic
Bought
2,452
$1.01K
26.5%
CATX
Perspective Therapeutics, Inc.
24 Nov 2017
Controller/Prin Fin&Acct Offic
Bought
2,040
$1.00K
28.2%
CATX
Perspective Therapeutics, Inc.
22 Nov 2017
Controller/Prin Fin&Acct Offic
Bought
1,825
$894.25
33.8%
CATX
Perspective Therapeutics, Inc.
21 Nov 2017
Controller/Prin Fin&Acct Offic
Bought
5,400
$2.59K
opened
8 decisions on file.
